• Intelligent Technology: Impacting the Future of Clinical Research

    Clinical Research News | Today’s clinical trial landscape is incredibly complex to navigate. A prevailing issue is inefficiency—relying on years of approved and proven SOPs that can result in expensive delays and increased burdens for patients, sites and sponsors. The good news is disruptive technologies—specifically artificial intelligence—are tangibly resolving challenges inherent to the clinical trial process.

    May 6, 2021

  • ERT and Bioclinica Close Merger, Parexel and Veeva Collaborate, More

    Clinical Research News | Mergers and strategic collaborations link data from devices and sensors, streamline research workflows, and aim to accelerate clinical trials. Plus, updated CTMSs, expanded CROs, and more new products and updates from around the industry.

    May 3, 2021

  • Why Imaging Biomarkers Represent the Next Generation of Personalized Drug Development

    Clinical Research News | Imaging biomarkers, which are generated through the science of radiomics (think: advanced imaging analytics), are likely to play in the future of personalized drug development. Today, private industry and academia are collaborating on research to discover and develop new imaging biomarkers to add a new layer to the personalization of medicine.

    Apr 30, 2021

  • Seqster’s Series A, Investments in Digital Trials, and Virtual Care Delivery

    Clinical Research News | Medable nets cash to deliver decentralized trials; more money for telemedicine and telehealth delivery, investments in healthcare data platforms, and more.

    Apr 29, 2021

  • Medable: Real-World Evidence Needed To Address Health Disparities

    Clinical Research News | The pandemic has served to highlight the value of real-world evidence (RWE) in personalizing the delivery of care and potentially reducing disparities in access to treatment options, including clinical studies. To explore this “new frontier,” Medable has contracted with Kaiser Permanente to develop mobile apps designed to capture insights from informal caregivers, and digital biomarkers from wearable devices with patients, in fully decentralized trials.

    Apr 26, 2021

  • Biomarker Discovery Reveals Role of Lipids in Age-Related Pathologies

    Clinical Research News | Senescent cells can be good or bad actors when it comes to human health, but their steady accumulation with aging has adverse consequences that pharmaceutical companies are keen on reversing. Determining if a senolytic drug is working in the human body is a tough proposition, however, since the testing process often involves a biopsy and waiting long periods of time to determine whether a pathology has been ameliorated.

    Apr 21, 2021

  • How to Make Translations Work for Everyone

    Clinical Research News | When conducting a clinical trial on a global scale, sponsors assume a certain amount of risk in addition to significant management challenges, many of which can be attributed to communication. For this reason, comprehensive translation strategies are important to consider prior to moving forward with a clinical trial.

    Apr 19, 2021

  • Sanofi Reaping Rewards Of Site- And Patient-Centric Clinical Development

    Clinical Research News | Sanofi has succeeded in accelerating its clinical development timeline year over year, in large part by viewing patients as customers and key opinion leaders (KOLs), according to Victoria DiBiaso, vice president and regional head of the clinical studies unit in Asia Pacific, Eurasia, Middle East, and Africa. “What that means for patients is that we are developing meaningful healthcare solutions that are addressing unmet needs and we are doing it faster.”

    Apr 14, 2021

  • Patient Driven-Data: The Key to Improving the Health Ecosystem

    Clinical Research News | What are the benefits of Personal Health Records (PHRs) are, not just to patients, but to the wider health system? The most straightforward answer is this: patients who are engaged in their healthcare and understand their condition have better health outcomes. PHRs have a vital role to play in patient empowerment, effective clinical trials, and preventative and precision medicine around the world.

    Apr 13, 2021

  • Addressing Social Determinants Of Health To Improve Clinical Trial Diversity

    Clinical Research News | Health equality does not assure health equity, where the focus is on fixing root problems so access to tools and resources is possible across populations, according to Laurie Myers, global health literacy director at Merck.

    Apr 9, 2021

  • Pharma Needs To Better Understand Patients In Their Lived Environments

    Clinical Research News | Social and behavioral science is critical to the generation of real-world evidence (RWE) that reflects the patient perspective, according to Emily Freeman, Ph.D., senior director of patient insights in global R&D at Lundbeck Pharmaceuticals, and generating that evidence requires more multi-disciplinary expertise than is currently being brought to the table.

    Apr 8, 2021

  • At Janssen, Data Analytics Is Pivotal To Trial Success

    Clinical Research News | Janssen is using two homegrown data analytics solutions at scale to optimize clinical trials, enabling internal teams to solve real use cases embedded in the development process. The company is infusing real-world data (RWD) and data science into long-established processes to increase the operational success of trials and minimize patient burden.

    Apr 7, 2021

  • Leading After the Pandemic: Strategies to Guide the Future of Clinical Research

    Clinical Research News | A COVID-19 vaccine in one year is no small feat! What made it possible was the industry coming together in unprecedented ways and operating with a sense of urgency, spurring global cooperation for vaccine research, innovation, and distribution. We need to maintain this momentum at this critical junction, strengthen partnerships, and apply our learnings and knowledge to optimize clinical trials and accelerate the drug development process.

    Apr 6, 2021

  • Follow the Money: Remote Patient Monitoring, Real-World Data Networks, Trial Diversity

    Clinical Research News | PatientsLikeMe raises a new round of funding to expand, and several companies get investments for remote patient monitoring and medication adherence. Mount Sinai leads team tasked with decreasing the disparities in cancer trials. And new investment funds for late-stage companies and public health.

    Apr 1, 2021

  • How Cerevel Therapeutics Put Hybrid Trials Into Practice

    Clinical Research News | Cerevel Therapeutics is looking at new studies in a different way after test-driving an assortment of virtual trial options when the pandemic hit. Remote site initiation visits and remote monitoring will be permanent fixtures moving forward, and the incorporation of home health visits also appears promising, according to Laura Whitmore, director of clinical operations oversight

    Mar 31, 2021

  • Interest Brewing In A One-Stop Platform For Trial Participants

    Clinical Research News | A panel discussion on the move toward “platform thinking” in pharma roused lively discussion and exchange with attendees at the recent Summit for Clinical Ops Executives (SCOPE). Interest was particularly high in development of a common platform catering to the needs of patients and disconnected from any drug, protocol, or sponsor.

    Mar 30, 2021

  • Takeda Using Chatbot To Improve Patient-Centricity And Trial Design

    Clinical Research News | Takeda Pharmaceuticals has developed a digital chatbot assistant to provide integrated and continuous support for patients with chronic diseases at risk of serious event occurrences and frequent emergency room visits. The learnings are expected to help clinical trials become more patient-centric and less labor-intensive to conduct.

    Mar 29, 2021

  • The Importance of Early Phase Trials in Precision Oncology

    Clinical Research News | Nowadays, drug development in oncology is largely centered on the basic premise of precision medicine, according to which targeted agents are used based on the expression of predictive biomarkers. Even though late-phase trials of precision oncology are undergoing transformations, we believe that the greatest impact of precision oncology has been in the design of early-phase trials.

    Mar 25, 2021

  • Data Exchange Standards Are Focus Of TransCelerate’s eSource Initiative

    Clinical Research News | TransCelerate’s eSource initiative supporting decentralized clinical trials aims to add efficiency to the clinical research process by facilitating the exchange of data between sites and sponsors and “filling the gaps” in the primary data interchange standards governing electronic health record (EHR) systems.

    Mar 24, 2021

  • AbbVie Quantifying Burden Of Clinical Trial Participation

    Clinical Research News | AbbVie is developing a patient burden algorithm to quantify the onus of trial-related procedures on study participants, according to Allam Fakhoury, PharmD, the company’s head of portfolio design and execution, at a presentation he made at last week’s Summit for Clinical Ops Executives (SCOPE).

    Mar 23, 2021